News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Pfizer Inc.'s Drug for Nerve Pain, Lyrica Gets Expanded Approval In Japan
October 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Oct 28 (Reuters) - Japanese health regulators approved Pfizer Inc's (PFE.N) Lyrica to treat a type of nerve pain called peripheral neuropathic pain, Pfizer said on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Pfizer
MORE ON THIS TOPIC
Government
FDA to Rehire Some Travel Staff as Lapses Begin to Show:
AP
May 2, 2025
·
2 min read
·
Tristan Manalac
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
May 1, 2025
·
3 min read
·
Heather McKenzie
Approvals
J&J Steps Into Crowded Myasthenia Gravis Market With FDA Nod
May 1, 2025
·
2 min read
·
Tristan Manalac
Government
FDA Misses Another Deadline Amid Staff Exodus, Structural Disruptions
May 1, 2025
·
2 min read
·
Tristan Manalac
